Rethinking Clinical Trials

NOVEMBER 16, 2022

Associate Director, Center for Bioethics & Social Sciences in Medicine. Ethics, Data Sharing, Pragmatic Clinical Trials. For PCTs, data volume is potentially larger, data may be “about” those beyond patient-subjects (i.e. Assistant Professor of Obstetrics & Gynecology. University of Michigan Medical School.

Clinical Trials 246

Clinical Trials Clinical Trials Trials Research 246

Roots Analysis

JANUARY 28, 2024

Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. Within the healthcare sector, structured data includes demographic details, vital indicators (like, height, weight, blood pressure, blood glucose).

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

pharmaphorum

OCTOBER 18, 2022

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.

Drug Delivery 52

Drug Delivery Manufacturing Drugs Marketing 52

Pharmaceutical Technology

JUNE 29, 2022

In a series of data-driven deep dives, we will examine how the development of orphan drug therapies has evolved over the years, and use the FDA’s orphan drug program as a barometer of these advances. What happens after a drug gets an orphan drug designation?

Drugs 246

Drugs FDA Approval Marketing Development 246

pharmaphorum

SEPTEMBER 15, 2020

This gives them huge amounts of customer data that allows them to shape and personalise the way they engage with their customers, not least thanks to the direct-to-consumer sales model they often offer. Jeremy Richter, Tag. Build on the rapid responses to COVID-19. About the interviewees.

Branding 130

Branding Marketing Pharma Companies Life Science 130

The Pharma Data

OCTOBER 9, 2021

This designation is predicated on data showing that gantenerumab significantly reduced brain amyloid pillar, a pathological hallmark of Notice, in the ongoing SCarlet RoAD and Marguerite RoAD open- tag extension trials, as well as other studies. Roche’s Chief Medical Officer and Head of Global Product Development.

Antibody 52

Antibody In-Vitro Trials Development 52

XTalks

AUGUST 17, 2020

The founder of Cue Biopharma, Steven C Almo, PhD, current chair of biochemistry at Albert Einstein College of Medicine, is a renowned protein engineer in the field who approached immune recognition from the perspective of a protein engineer rather than an immunologist. Targeting WTI and KRAS-Driven Tumors.

Protein 98

Protein Engineer Immune Response In-Vivo 98